Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms

Lori A. Erickson, Long Jin, Thomas J. Sebo, Christine Lohse, V. Shane Pankratz, Michael L. Kendrick, Jon A. van Heerden, Geoffrey B. Thompson, Clive S. Grant, Ricardo V. Lloyd

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

We analyzed a series of adrenocortical neoplasms to compare the clinicopathologic features and the expression of insulin-like growth factor-2 (IGF-2) in adrenocortical adenomas and carcinomas. IGF-2 is a growth factor commonly expressed in many tumors including adrenal cortical and medullary neoplasms. Formalin-fixed paraffin-embedded tissues from 64 adrenocortical adenomas and 67 adrenocortical carcinomas were analyzed. The carcinomas were histologically graded from 1 to 4 based on mitotic activity and necrosis. Tumor weight, size, and follow-up information were obtained by chart review. Expression of IGF-2 was detected by immunohistochemistry with the avidin-biotin-peroxidase complex method and a monoclonal antibody against IGF-2. Adrenocortical carcinomas were larger (mean: 13.1 cm, 787 g) than adenomas (mean: 4.2 cm, 52 g) (p < 0.001). In patients with adrenocortical carcinomas, high tumor grade (3 or 4) (p = 0.01) was associated with decreased survival. Expresssion of IGF-2 was higher in adrenocortical carcinomas than in adenomas (p < 0.001). These results show that tumor size and weight along with expression of IGF-2 protein are useful features to assist in distinguishing between adrenocortical adenomas and carcinomas, and that high tumor grade is a predictor of survival in adrenocortical carcinomas. However, single immunohistochemical markers such as IGF-2 or single histopathologic features cannot by themselves separate adrenocortical adenomas from carcinomas, and a combination of clinical, gross, and microscopic features are needed to establish the diagnosis in difficult cases.

Original languageEnglish (US)
Pages (from-to)429-435
Number of pages7
JournalEndocrine Pathology
Volume12
Issue number4
DOIs
StatePublished - Jan 1 2001

Keywords

  • Adrenocortical adenoma
  • Adrenocortical carcinoma
  • Insulin-like growth factor-2

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms'. Together they form a unique fingerprint.

  • Cite this

    Erickson, L. A., Jin, L., Sebo, T. J., Lohse, C., Pankratz, V. S., Kendrick, M. L., van Heerden, J. A., Thompson, G. B., Grant, C. S., & Lloyd, R. V. (2001). Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms. Endocrine Pathology, 12(4), 429-435. https://doi.org/10.1385/EP:12:4:429